EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Effect of Combination Use of Aqueous Humor Secretion Inhibitor Eye Drops on Aflibercept Level: A Preliminary Analysis

Satoru Inoda, Hidenori Takahashi, Ryota Takahashi, Yuto Hashimoto, Hana Yoshida, Hironori Takahashi, Yujiro Fujino, Kenichi Aizawa, Hidetoshi Kawashima, Yasuo Yanagi

Translational Vision Science & Technology · 2025

DOI: 10.1167/tvst.14.2.21 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Translational Vision Science & Technology, 2025. Verfasst von Satoru Inoda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Aqueous Humor, Glaucoma, Receptors, Vascular Endothelial Growth Factor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the association between aqueous humor (AH) suppressant eye drops and the concentration of aflibercept at 1 month after intravitreal injection.

Methods

This retrospective study included 17 eyes of 17 patients with neovascular age-related macular degeneration (nAMD) who used eye drops for their glaucoma and received their first intravitreal aflibercept (IVA) at two centers between July 2013 and November 2020. As controls, we enrolled 40 age-, sex-, and axial length-matched eyes of 40 patients with nAMD who were not using any medication that would affect AH circulation. AH was collected 1 month after the first IVA. Aflibercept levels were measured by enzyme-linked immunosorbent assay and were compared between controls and cases using the Kruskal-Wallis test and Dunn's test. The drugs were categorized into two groups based on their mechanism of action on the AH: outflow drugs (e.g., prostaglandin analog) and inflow drugs (e.g., carbonic anhydrase inhibitor, beta-blockers, and alpha-2 agonists).

Results

Mean (interquartile range) aflibercept levels in the AH in controls and in cases who used outflow and inflow drugs were 6.83 µg/mL (1.94-10.34), 9.93 µg/mL (2.58-17.44), and 15.95 µg/mL (7.20-22.57), respectively. A Kruskal-Wallis test showed a significant difference among the control, inflow, and outflow drugs (P = 0.0075). Dunn's test showed that aflibercept levels in the aqueous humor were significantly higher in cases using inflow drugs compared to both controls and cases using outflow drugs (P = 0.0085 and P = 0.044, respectively).

Conclusions

Aflibercept levels in the AH 1 month after the first IVA were higher in cases using eye drops that reduce AH secretion than in controls. Translational Relevance: Our results, together with previous studies in animals, suggest that combined use of these eye drops might extend the half-life of intravitreally injected drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsAqueous HumorGlaucomaReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsWet Macular DegenerationAgedAged, 80 and overFemaleHumansMaleMiddle AgedIntravitreal InjectionsOphthalmic SolutionsRetrospective StudiesCase-Control Studies

Substanzen

afliberceptAngiogenesis InhibitorsOphthalmic SolutionsReceptors, Vascular Endothelial Growth FactorRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan.
  • Department of Ophthalmology, Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, Tokyo, Japan.
  • Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan.
  • Clinical Pharmacology Center, Jichi Medical University Hospital, Tochigi, Japan.
  • Department of Ophthalmology and Micro-Technology, Yokohama City University, Yokohama, Japan.
  • Retina Research Group, Singapore Eye Research Institute, Singapore Eye-ACP, Duke-NUS Medical School, National University of Singapore, Singapore.

Zitieren

APA

Inoda, S., Takahashi, H., Takahashi, R., Hashimoto, Y., Yoshida, H., Takahashi, H., Fujino, Y., Aizawa, K., Kawashima, H., & Yanagi, Y. (2025). Effect of Combination Use of Aqueous Humor Secretion Inhibitor Eye Drops on Aflibercept Level: A Preliminary Analysis. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.14.2.21

Vancouver

Inoda S, Takahashi H, Takahashi R, Hashimoto Y, Yoshida H, Takahashi H, et al. Effect of Combination Use of Aqueous Humor Secretion Inhibitor Eye Drops on Aflibercept Level: A Preliminary Analysis. Translational Vision Science & Technology. 2025. doi:10.1167/tvst.14.2.21

BibTeX
@article{Inoda2025,
  author = {Inoda, Satoru and Takahashi, Hidenori and Takahashi, Ryota and Hashimoto, Yuto and Yoshida, Hana and Takahashi, Hironori and Fujino, Yujiro and Aizawa, Kenichi and Kawashima, Hidetoshi and Yanagi, Yasuo},
  title = {Effect of Combination Use of Aqueous Humor Secretion Inhibitor Eye Drops on Aflibercept Level: A Preliminary Analysis},
  journal = {Translational Vision Science & Technology},
  year = {2025},
  doi = {10.1167/tvst.14.2.21}
}
Kostenlos starten →